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Abstract
Aims/hypothesis Pregnancy requires an increase in the
functional beta cell mass to match metabolic needs for
insulin. To understand this adaptation at the molecular
level, we undertook a time course analysis of mRNA
expression in mice.
Methods Total RNA extracted from C57Bl6/J mouse islets
every 3 days during pregnancy was hybridised on commer-
cially available expression arrays. Gene network analysis
was performed and changes in functional clusters over time
visualised. The function of putative novel cell cycle genes
was assessed via silencing in replicating mouse insulinoma
6 (MIN6) cells.
Results Gene network analysis identified a large gene
cluster associated with cell cycle control (67 genes, all
upregulated by ≥1.5-fold, p<0.001). The number of
upregulated cell cycle genes and the mRNA expression
levels of individual genes peaked at pregnancy day (P)9.5.
Filtering of poorly annotated genes with enhanced expres-
sion in islets at P9.5, and in MIN6 cells and thymus
resulted in further studies with G7e ( a l s ok n o w na s
D17H6S56E-5) and Fignl1. Gene knock-down experiments
in MIN6 cells suggested that these genes are indeed
involved in adequate cell cycle accomplishment.
Conclusions/interpretation A sharp peak of cell cycle-
related mRNA expression in islets occurs around P9.5,
after which beta cell replication is increased. As illustrated
by the identification of G7e and Fignl1 in islets of pregnant
mice, further study of this distinct transcriptional peak
should help to unravel the complex process of beta cell
replication.
Keywords Beta cell.Cell cycle.Fignl1.G7e.Islets of
Langerhans.Pregnancy.Replication
Abbreviations
CFSE Carboxyfluorescein succinimidyl ester
MIN6 Mouse insulinoma 6
Mki67 Antigen identified by monoclonal antibody Ki67
P Pregnancy day
siRNA Small interfering RNA
Introduction
An important objective in islet research is to understand
how functional beta cell mass is controlled [1–3]. Powerful
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and release to meet metabolic demands, since the latter is
known to fluctuate during healthy life [4, 5] and to increase
in conditions associated with insulin resistance [6]. Because
excess and shortage of insulin are harmful to the organism,
the regulation of beta cell proliferation has to be very
precise. As in other cell types, control of the cell cycle in
beta cells hinges on the transition between G0 and G1, and
involves interactions between cyclin D isoforms, cyclin-
dependent kinases and cyclin-dependent kinase inhibitors
[2, 3]. Knockout and transgenic mouse models of these
genes have inadequate beta cell mass phenotypes, protect-
ing or predisposing to spontaneous or environmentally
induced diabetes [2, 3, 7]. Recent molecular studies have
led to a better insight into how cell cycle is regulated in
beta cells [2, 3, 8]. For instance, the well-known declining
potential for beta cell replication with advancing age is
associated with increased cyclin-dependent kinase inhibitor
2A activity caused by loss of Bmi1 expression [9]. An
increased metabolic insulin demand together with a
moderate degree of insulin resistance during pregnancy
drives functional beta cell mass expansion [10]. The latter
occurs via a gain of function of pre-existing beta cells [11]
and enhanced beta cell replication [12, 13]. Prolactin
receptors are known to be essential for such adaptation
[11, 14, 15]; however, knowledge of the transcriptional
response they trigger is still fragmentary. In addition, recent
s t u d i e sr e p o r t e dar o l ef o rM e n i n1[ 16], a tumour
suppressor associated with multiple endocrine neoplasia
type 1 [17], and for the transcription factor forkhead box
M1 [18–21]. However, their relationship with cell cycle
genes is still incompletely understood. To better understand
beta cell replication, genome-wide mRNA expression analy-
sis in islets from pregnant female animals has been used to
screen for novel mechanisms [22]. We undertook a time
course analysis of the transcriptional changes occurring in
mouse pancreatic islets of Langerhans during pregnancy,
isolating islets every 3 days of pregnancy. This detected a
thus far unrecognised peak of cell cycle related gene activity
on pregnancy day (P)9.5, which is just before mid-term.
Methods
Islet isolation All experiments with laboratory animals
were approved by the committee for animal welfare at
the Katholieke Universiteit Leuven, Belgium. Islets of
Langerhans from female C57Bl6/J mice (Janvier, Le
Genest-saint-Isle, France) were collagenase isolated as
previously described [23]. Other tissues were dissected
from 10- to 12-week-old male C57Bl6/J mice (Janvier).
T i s s u e sw e r er i n s e di nP B S ,f r o z e ni nl i q u i dn i t r o g e na n d
stored at −80°C.
Cell culture Mouse insulinoma 6 (MIN6) cells were
cultured in DMEM (Invitrogen, Carlsbad, CA, USA)
with 25 mmol/l glucose equilibrated with 5% CO2 and
95% air at 37°C. The medium was supplemented with
15% (vol./vol.) decomplemented fetal calf serum (Invitrogen,
Paisley, UK), 70 μmol/l β-mercaptoethanol, 4 mmol/l gluta-
max, 50 U/ml penicillin and 50 μg/ml streptomycin. MIN6
cells were used between passages 20 and 30.
mRNA expression analysis via microarray Total RNA from
mouse islets and MIN6 cells was extracted using a kit
(Absolutely RNA microprep; Stratagene, La Jolla, CA,
USA) according to the manufacturer’s protocol. Total RNA
was extracted from the other tissues as described previously
[24]. The total RNA quantity and quality was determined
using a spectrophotometer (ND-1000; NanoDrop Technol-
ogies, Wilmington, DE, USA) and a bioanalyser (2100;
Agilent, Waldbronn, Germany), respectively.
The MOE430_2.0 arrays (Affymetrix, Santa Clara, CA,
USA) were used as previously described on samples from
P15.5 and non-pregnant females (n=4–5) [24]. To analyse
the time series of pregnancy, 100 ng islet total RNA (n=4
for each time point except P3.5 [n=3]) was used to
hybridise the arrays (MoGene_1.0_ST; Affymetrix) accord-
ing to the manufacturer’s manual 701880Rev4, as described
previously [23].
Data analysis To identify differentially expressed genes
between islets from non-pregnant and P15.5 mice with the
MOE430_2.0 and MoGene_1.0_ST arrays (p<0.001), the
probe sets of both platforms, unambiguously annotating the
same gene, were analysed, resulting in an expression
dataset of 17,337 genes. Differentially expressed genes in
the time course analysis were identified on the basis of a
fold change of ≥1.5 and p<0.001 at least at one of the
pregnancy time points as compared with non-pregnant
mice. The 415 differentially expressed genes were assigned
by Gene Ontology (http://www.geneontology.org/, accessed
April 2010) and consultation of the literature to cellular
processes. A network of these genes was built based on
multiple data sources obtained from String 8.0 [25], with an
edge confidence score of >0.15. The network thus created
was visualised in Cytoscape 2.6.1 (http://www.cytoscape.
org/, accessed April 2010). Only the genes belonging to one
of the five largest functional groups and having at least one
connection with another gene in the same group were
selected for visualisation, yielding a network of 130 genes.
See also Electronic supplementary material (ESM) methods
for heatmap and public microarray datasets analysis.
Quantitative RT-PCR After cDNA synthesis (RevertAid H
Minus Reverse Transcriptase kit; Fermentas, St Leon-Rot,
Germany), quantitative RT-PCR (Absolute QPCR mix;
2580 Diabetologia (2010) 53:2579–2588Abgene Thermo Fisher Scientific, Waltham, MA, USA)
was performed on a Rotorgene (Corbett Research, Mor-
tlake, NSW, Australia) to determine mRNA expression of
different genes (normalisation to RNA polymerase alpha II,
Polr2a). For primers and probes, see ESM Tables 1 and 2.
Quantification of relative beta cell proliferation Pancreases
were dissected from non-pregnant and pregnant female
mice (n=3 for each time point except P6.5 [n=2] and non-
pregnant [n=4]) and fixed in 4% (wt/vol.) paraformalde-
hyde. Next, paraffin sections were made and stained for
antigen identified by monoclonal antibody Ki-67 (Mki67)
and insulin using guinea pig anti-insulin (a gift from C. F.
H. van Schravendijk, Diabetes Research Center, Vrije
Universiteit Brussel, Brussels, Belgium) and rabbit anti-
Mki67 (Acris Antibodies, Hiddenhausen, Germany) [26].
Binding of primary antibodies was detected with biotiny-
lated anti-guinea pig and anti-rabbit Ig in combination with
streptavidin horseradish peroxidase and alkaline phospha-
tase complex; diaminobenzidine and fuchsin-plus were
used as substrates (all reagents from Dako, Glostrup,
Denmark). Quantification of MKi67-insulin double positive
cells was performed at ×400 magnification by two
independent observers. A minimum of 1,000 cells per
animal were evaluated.
RNA interference The small interfering RNAs (siRNAs)
used in the study are listed in ESM Table 3. MIN6 cells
loaded or not with the carboxyfluorescein succinimidyl
ester (CFSE) according to the manufacturer’s protocol (Cell
Trace CFSE Cell Proliferation Kit; Invitrogen, Paisley, UK)
were seeded in a 24-well plate and incubated for 24 h. For
transfection, siRNA and DharmaFECT1 (ThermoFisher
Scientific) were diluted separately in OptiMEM medium
and incubated at room temperature for 5 min. Next, lipid–
siRNA complexes were formed at room temperature for
20 min (1 μlD h a r m a F E C T 1 ,2 0p m o l / lF i g n l 1o r
100 pmol/l siRNA [non-target, Dlk1, Kif11 and G7e]).
The complexes were diluted and added to the cells for
overnight transfection. Afterwards, cells were cultured for
24 to 48 h before mRNA extraction.
Analysis of proliferation and cell death On the 6th day after
siRNA transfection, trypsinised CFSE-loaded MIN6 cells
were resuspended in PBS containing 2 μg/ml propidium
iodide to avoid contamination due to cell fragments or
apoptotic cells. The fluorescence intensity of the cells was
measured by flow cytometry. To determine the effect of
silencing on the number of cells after culture, we took
advantageofthetimerequiredtoacquireaconstantnumberof
cells with the flow cytometer (Epix XL; Beckman-Coulter,
Miami, FL, USA). From this time, the cell concentration of
eachsamplecouldbededucedasCx=N/Tx (N being the fixed
number of cells acquired, while Tx is the time necessary for
cell acquisition from sample x). The percentage of MIN6
cells retrieved was calculated as P ¼ Cx=CNT ðÞ   100 (where
Cx is the concentration of cells retrieved in sample x, while
CNT is the concentration of control MIN6 cells transfected
with a non-target siRNA).
The proportion of apoptotic plus necrotic MIN6 cells
was determined 48 h after siRNA transfection by their
fluorescence intensity after staining with 2 μg/ml propi-
dium iodide (dissolved in PBS) for 30 min at 4°C.
Results
Pancreatic islet mRNA expression of cell cycle genes peaks
at day 9.5 of pregnancy To better understand the transcrip-
tional response in islets of Langerhans during pregnancy,
we assessed mRNA signals of islets ex vivo using
MoGene_1.0_ST arrays. Since the time kinetics of changes
in functional beta cell mass are not well characterised, we
sampled islets every 3 days of pregnancy in the mouse, i.e.
at P3.5, P6.5, P9.5, P12.5, P15.5 and P18.5, as well as
10 days postpartum, and compared their mRNA expression
levels with those of non-pregnant age-matched controls. We
found 415 differentially expressed genes defined by a fold
change of ≥1.5 (up or down) and p<0.001 for at least one
time point of pregnancy/lactation vs non-pregnant controls.
These differentially expressed genes were mapped to their
main functional process, while interactions were extracted
from multiple data sources using String 8.0 [25]. Next, we
performed a network analysis of the encoded proteins.
Figure 1 visualises the five largest functional categories
related to the differentially expressed genes during the time
course of pregnancy. Almost all genes in the network were
upregulated (95%). In this representation, the largest
functional category (more than 50% of all the characterised
and differentially expressed genes) encoded proteins in-
volved in cell cycle. Remarkably, the expression of every
gene in this cluster was upregulated at P9.5 (Fig. 1), while
before and after this time point fewer cell cycle genes were
differentially expressed (ESM Fig. 1). This functional
cluster was not exclusively composed of positive cell cycle
regulators, but also contained one inhibitor, Cdkn2c, which
is a member of INK4a/ARF family and peaked at the same
time point (ESM Fig. 2). In contrast, genes linked to other
functional clusters (metabolism, signal transduction, cell
growth and differentiation, and protein synthesis) did not
exhibit a similar peak at P9.5, but were also altered at later
time points, even at 10 days postpartum (ESM Fig. 1). In
addition, we also found that the individual expression levels
of all cell cycle genes in Fig. 1 peaked at P9.5 as illustrated
in the heatmap representation (ESM Fig. 3). To further
illustrate this point, we focused on three well characterised
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topoisomerase 2-alpha [Top2a]), mRNA expression profiles
of which were tightly correlated (R>0.95; p<0.0001), both
at the level of expression in tissues that widely differ in
number of proliferating cells (ESM Fig. 4a), and at the level
of islets at different time points of pregnancy (ESM
Fig. 4b). Together, we observed a clear time-dependent
induction of cell cycle genes in islets from pregnant mice
with a distinct maximum of mRNA expression centred at
P9.5.
Islet beta cell proliferation peaks between the 2nd and 3rd
week of mouse pregnancy The maximal transcriptional
activity of cell cycle genes observed at P9.5 occurred 3 to
6 days before the peak of effective mouse beta cell
proliferation during pregnancy as described in literature
[12]. To better understand this difference, we confirmed by
quantitative RT-PCR analysis the time course of Mki67
mRNA expression in islets during pregnancy (Fig. 2a). In
parallel, we quantified Mki67/insulin immunoreactive cells
in pancreatic sections at the same time points (Fig. 2b, c).
In control islets, less than 3% of beta cells were
proliferating. This number doubled at P9.5 (p<0.001), but
a further rise in proliferating beta cells (~8–9%) was
achieved between P12.5 and P15.5. After this peak, the
amount of proliferating beta cells returned to baseline by
P18.5 and became significantly lower than baseline
postpartum. In contrast, Mki67 mRNA was still upregulated
at P18.5 and 10 days postpartum as compared with non-
pregnant islets. These data indicate that the orchestrated
short peak of transcriptional activity of cell cycle genes is
followed by several days of beta cell replication. Moreover,
the different time kinetics between Mki67 mRNA and
protein in islets indicates a time-dependent translational
control for this protein.
Two putative new cell cycle genes with highest mRNA
expression in islets isolated on P9.5 A limitation of the
network analysis used (Fig. 1) is that poorly annotated
genes with uncharacterised function were excluded. Since
some of these genes showed the same expression profile as
the well characterised genes of the cell cycle cluster,
including the distinct peak of transcription at P9.5, it is
conceivable that such genes could play a role in cell cycle
control of replicating beta cells during pregnancy. We
therefore re-analysed from the set of 415 differentially
expressed genes during pregnancy the 267 genes that were
significantly upregulated on P9.5 (fold change ≥1.5, p<
0.001). To enrich this group with proliferation-related
genes, we next selected transcripts that were at least tenfold
more abundant in thymus (269 genes from the whole array)
and at least fivefold more abundant in the proliferating
mouse beta cell line MIN6 (182 genes from the whole
array) than in non-pregnant islets (Fig. 3a). Both conditions
were chosen because of their enrichment of proliferating
cells. Via this strategy 41 genes (including Mki67, Top2a
and Ccna2) were seen to be represented in the overlapping
area of the Venn diagram (Fig. 3a) and were listed
according to gene symbol in Fig. 3b. According to Gene
Ontology annotation, 35 of these 41 genes were classified
as cell cycle genes, of which 30 were also selected as genes
of the cell cycle category in our first analysis in ESM
Fig. 1. In contrast, Arhgap11a was the sole exception
assigned to the signal transduction category by Gene
Ontology analysis. Among the remaining five genes, three
were not yet correctly classified in Gene Ontology, but the
literature indicated that these were indeed cell cycle genes,
namely C330027C09Rik, C79407 and 2810417H13Rik,
which (or human homolog) are now respectively called
P3.5
P9.5
P12.5
P15.5
P18.5
10 dpp
P6.5
Fig. 1 Pregnancy-induced changes in islet mRNA expression.
Network analysis, using String 8.0 and Cytoscape 2.6.1, of 130 genes
with expert-assigned gene ontology that were found to be differen-
tially expressed during one time point of pregnancy (P3.5, P6.5, P9.5,
P12.5, P15.5, P18.5) or lactation (10 days postpartum [10 dpp]) as
compared with non-pregnant control islets. Differentially expressed
genes (fold change vs non-pregnant ≥1.5, p<0.001) with known
function were clustered according to function. Representation is
limited to genes that had at least one connection with another gene
in the same group. The five largest functional categories in this figure
are indicated by coloured circle outlines as follows: cell cycle (red),
metabolism (green), signal transduction (brown), protein synthesis,
modification and folding (purple), and beta cell growth and differen-
tiation (blue). Circle shading indicates: yellow, gene upregulated; dark
grey, gene downregulated ≥1.5 and p<0.001. Data analysis was
performed as described in the Methods. Symbols of individual genes
are listed for each cluster in ESM Fig. 3
2582 Diabetologia (2010) 53:2579–2588Cip2a, Mis18bp and p15(PAF) [27, 28]. Fignl1 had already
been linked to the cell cycle, but up to now with discrepant
effects [29, 30]. The last gene called, G7e, also known as
D17H6S56E-5, was essentially uncharacterised, although
located in a tumour susceptibility locus [31, 32]. Expression
of Fignl1 and G7e was strongly correlated with essential
cell cycle genes in public human and mouse microarray
databases, analysed via Multi Experiment Matrix: MEM
[33] (ESM Tables 4 and 5). Fignl1 was also overexpressed
in different human cancers (ESM Table 6)[ 34], whereas
G7e could not be analysed with the human arrays, as it is
rodent-specific. Therefore, we chose the last two genes,
G7e and Fignl1, to study their contribution to cell cycle in
proliferating MIN6 cells.
Effect of G7e and Fignl1 silencing on proliferation of MIN6
cells The idea that G7e and Fignl1 are related to the cell
cycle is supported by the following observations. First,
mRNA expression of G7e and Fignl1,a sw e l la so f
Arhgap11a, Mis18bp and 2810417H13Rik correlated well
with Mki67 mRNA expression in the individual islet
preparations examined during pregnancy, with the highest
expression level occurring in P9.5 islet samples (Fig. 4).
These data were confirmed by quantitative RT-PCR, as well
as for Top2a and Mis18bp (Fig. 2a, ESM Fig. 5). To further
characterise the function of these putative new cell cycle
genes, we silenced their expression by RNA interference
(siRNA) in proliferating MIN6 cells. As a positive control,
we silenced Kif11, a known cell cycle gene, whereas as a
negative control we used siRNA targeting Dlk1. For all four
tested genes, 60 to 90% silencing was achieved (Fig. 5a).
On the basis of a flow cytometric analysis, we found no
influence on proliferation when MIN6 cells were trans-
fected with siRNA directed against Dlk1 since the same
number of cells (94±10%, n=3) was obtained as compared
with non-target control, which was set to 100% for each
experiment (Fig. 5b). In contrast, silencing of Kif11 resulted
in a significant reduction (43±7%, p<0.001, n=5) as
compared with non-target. In addition, silencing of G7e or
Fignl1 also led to a significant reduction of MIN6 cells
(63±2%, p<0.001 and 58±8%, p<0.001 respectively). The
reduced number of cells could be the consequence of
impaired cell cycle entry (G0-G1 transition), cell-cycle
progression (G1-M) or enhanced cell death due to cell cycle
checkpoint alert. To distinguish between these possibilities,
we first tested the effect of siRNA on entry in the S-phase
by 5-ethynyl-2′-deoxyuridine incorporation. As shown in
ESM Fig. 6, none of the silenced genes was able to change
the rate of cells that entered the S-phase. Next, the reduced
ability to proliferate was tested via the loss of CFSE
fluorescence of coloured cells (Fig. 6), since the intensity of
the fluorescent dye is diluted two times at each round of
cell division, thereby allowing us to follow individual cell
division history [35]. The percentage of ‘CFSE-high’ cells
(i.e., cells that are replicating slowly) (Fig. 6) was measured
6 days after transfecting MIN6 cells with non-target siRNA
or siRNA directed against Kif11, G7e or Fignl1. The
percentage of cells replicating slowly in non-treated
controls (20±2%) was significantly (p=0.01) lower than
in the condition of Kif11 knockdown (31±4%). Likewise,
knockdown of G7e resulted in a significantly (p=0.005)
greater number of slowly replicating cells (32±2%). In
contrast, no increment in slowly replicating cells was found
after knockdown of Fignl1 (21±1%; p=0.64).
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Fig. 2 Islet Mki67 mRNA expression and protein level during
pregnancy. a Mki67 mRNA expression, measured via quantitative
RT-PCR, reached a peak at P9.5. Data represent mean±SEM of three to
four independent experiments (except P6.5, n=2) and are presented as
fold change over the non-pregnant condition. b Beta cell proliferation
(expressed as % of insulin-positive cells) was assessed by Mki67
immunostaining of pancreatic sections. This percentage peaked at
P12.5, i.e. 3 days after the peak mRNA expression level. Data
represent mean±SEM, three animals per time point (except non-
pregnant, n=4 and P6.5, n=2). ND, not determined. *p<0.05, **p<
0.01 and ***p<0.001 for difference between non-pregnant and
pregnant or postpartum conditions. c Representative images of
Mki67 immunoreactivity (brown) in insulin-positive beta cells (pink)
of islets in pancreatic sections from non-pregnant (NP) and P9.5 mice
Diabetologia (2010) 53:2579–2588 2583In a third assay, we stained MIN6 cells with propidium
iodide and counted the number of apoptotic plus necrotic
cells. Silencing of Kif11 enhanced the number of dead
MIN6 cells with an increase of 23±11% as compared with
non-target controls (p=0.015, n=3) and an even stronger
effect seen when Fignl1 was silenced (39±14% dead cells
above basal, p=0.003, n=3). In contrast, silencing of G7e
did not affect the rate of MIN6 cell death. Altogether, our
data support the idea that G7e and Fignl1 should be
considered as genes that contribute to the cell cycle of beta
cells; Fignl1 also seems to control cell survival.
Discussion
To better understand the complex mechanism of beta cell
mass regulation during pregnancy, we undertook a genome-
wide mRNA analysis of mouse islets ex vivo, conducted on
every third day of pregnancy. This approach is different
from that used in the study by Rieck et al., which focused
on the last third of gestation when the effective functional
beta cell mass expands most dramatically [22]. With this
approach, we were able to reconstitute a time course of
mRNA changes related to the cell cycle and observed a
sharp peak at an unexpected early time point, namely P9.5,
during which a large cluster of genes related to the cell
cycle was upregulated. Most of these genes encode cell
cycle activators. However, Cdkn2c, a member of the
INK4a/ARF family of inhibitors, also peaked at P9.5. This
could mean that, in parallel to providing positive regulators
of cell division, beta cells are also prepared to slow down
the cell cycle. Regulation of cell cycle genes can occur at
other levels than mRNA expression, e.g. protein translation,
protein degradation, phosphorylation or cellular localisation
[36, 37]. Thus, a possible scenario is that mRNA steps
preparing to slow cell division are made at P9.5, whereas
the actual slowing process, based on phosphorylation and
localisation of the protein, occurs later in pregnancy.
Importantly, a temporary wave of cell cycle gene mRNA
expression, measured as a sharp peak of cell cycle gene
activity at mid-gestation in mouse islets, was followed by a
period of about 1 week of enhanced beta cell proliferation.
The mechanism supporting this sustained beta cell prolif-
eration during pregnancy is not known and needs further
investigation. While transcriptional activity seems to be
synchronised, the biological response of beta cells could be
heterogeneous. One possibility is that a repressor of mRNA
translation, for instance one or several micro-RNAs, has to
be removed before cell division can occur. Another
possibility is that the actual progress of beta cell replication
needs, in addition to cell-cycle control in other cell types, a
second signal for growth, which comes at a later time point.
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Fig. 3 Identification of novel cell cycle genes involved in beta cell
proliferation during pregnancy. a Microarray analysis was performed on
thymus, MIN6 cells and islets of Langerhans isolated from non-pregnant
and P9.5 mice. For 41 putative cell cycle genes (overlapping area
between three circles) the three following criteria were met: (1)
differential expression (fold change ≥1.5, p<0.001) in islets of P9.5 vs
non-pregnant mice; (2) increased expression in MIN6 cells (fold change
≥5, p<0.001) vs islets of non-pregnant mice; and (3) increased expression
in thymus as compared with control islets (fold change ≥10, p<0.001). b
The 41 putative cell cycle genes, listed according to the associated Entrez
Gene ID and ranked on basis of their expression induction in islets on
P9.5 as compared with non-pregnant control (maximum fold change).
Two of these genes, G7e and Fignl1, are poorly characterised and were
chosen for further studies. In addition, 2810417H13Rik, C330027C09Rik
and Mis18bp have emerged in the recent literature as cell cycle genes, but
were not listed in Gene Ontology annotation [27, 39, 40]. Arhgap11a was
classified as involved in cell signalling
2584 Diabetologia (2010) 53:2579–2588In this context it is interesting that well-known genes for
beta cell growth such as Akt (also known as Akt1) peaked
during the last week of pregnancy in our analysis.
By focussing on the time-dependent expression of cell
cycle genes at the peak time point of P9.5 in islets during
pregnancy, we were ableto screen for novel players inthe cell
cycle. We generated a list of 41 genes, of which 35 are well
characterised cell cycle genes according to current Gene
Ontology annotation. Arhgap11a is linked, according to its
Gene Ontology annotation, to signal transduction, not cell
cycle, possibly indicating that the protein it encodes could be
involved in the signal transduction initiating the cell cycle or
assisting in progression through G1/S transition as suggested
in literature [38]. It will be interesting to unravel the
signalling pathway in which Rho GTPase activating protein
11A is involved. Our mRNA analysis identified several
receptors (Insrr, P2ry1 and Ptprd) with expression peaking
before P9.5, suggesting that the encoded proteins could be
involved in early events preparing for the cell cycle.
The five remaining genes are still unclassified in Gene
Ontology and are annotated as poorly characterised genes.
The recent literature, however, connects several of these five
genes to cell division. For C330027C09Rik, C79407 and
2810417H13Rik, a role in the cell cycle is clearly emerging
[27, 39, 40], while G7e and Fignl1 are less well charac-
terised. Extensive mRNA expression data analysis from
public databases (ESM Tables 4–6)l i n k sG7e and Fignl1 to
cell division, both in normal tissues and in tumours. Using a
silencing approach in proliferating MIN6 cells, we showed
that downregulation of Fignl1 and G7e reduced cell
proliferation. Results of Fignl1 silencing were more compli-
cated to interpret, as we mainly observed an effect on cell
death, rather than on cell division; however, cell death could
also be secondary, due to a detrimental cell cycle arrest [41,
42]. Fignl1 is well conserved in eukaryotic cells (ESM
Fig. 7a). The literature on fidgetin-like 1 (FIGNL1) in
animal cell proliferation is conflicting. Thus in calvarial
cells and osteoblast cell line MC3T3-E1, silencing of
mRNA expression resulted in enhanced proliferation
[30]. In contrast, in Caenorhabditis elegans [29]o rm o u s e
islets and MIN6 cells, Fignl1 seems to have a positive
effect on proliferation. Remarkably, the rodent-specific
G7e (ESM Fig. 7b), located in the major histocompatibil-
ity complex class III, is homologous to the envelope
protein of murine leukaemia virus and maps in a lung
tumour susceptibility locus [31, 32]. The intriguing
possibility therefore is that a virally transduced gene
stably integrated in the mouse genome is expressed in a
regulated manner in order to support cell division, but also
controls susceptibility to tumour development.
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Fig. 4 Correlationbetweenputativenovelcellcyclegeneexpressionand
abundance of Mki67 mRNA in mouse islets. Six genes from the set of
41 (see Fig. 3) are not linked to the cell cycle according to current Gene
Ontology annotation. Microarray analysis showed that expression of
each of these six genes in islets from pregnant mice correlated with the
prototypic cell cycle marker Mki67 during pregnancy. Graph represent-
ing the transcriptional correlations during pregnancy of Mki67 with (a)
G7e (r=0.93, p<0.0001), (b) Fignl1 (r=0.75, p<0.0001), (c) Arh-
gap11a (r=0.93, p<0.0001), (d) 2810417H13Rik (r=0.74, p<0.0001),
(e) C330027C09Rik (r=0.93, p<0.0001), (f) Mis18bp (r=0.86, p<
0.0001), (g) Kif11 (positive control; r=0.93, p<0.0001) or (h) Dlk1
(negative control; r=0.30, p<0.10). White squares, non-pregnant; black
squares, P3.5; white rhombuses, P6.5; black rhombuses, P9.5; white
circles, P12.5; black circles, P15.5; black triangles, P18.5; white
triangles, 10 days postpartum. mRNA expression of these uncharac-
terised genes significantly correlated (Pearson r correlation coefficient
and p<0.0001) with Mki67 mRNA expression in islets during
pregnancy
Diabetologia (2010) 53:2579–2588 2585Kinesin family member 11 is involved in the correct
segregation of chromosomes [43–45] and was recently
reported as a potential pharmacological target of anti-cancer
drugs [46]. Kif11 was one of the cell cycle genes identified
in islets of pregnant mice with peak expression at P9.5;
interestingly, single nucleotide polymorphisms around this
gene are among the strongest genetic markers of type 2
diabetes in genome-wide association studies [47]. There-
fore, the reduced cell proliferation obtained after mild Kif11
silencing supports the idea that a genetic defect in human
KIF11 could predispose to type 2 diabetes via a beta cell
mass defect.
For technical or other reasons, we will have failed to
detect other genes that are important for beta cell
proliferation. Indeed, Foxm1 and Men1 were not found to
be differentially expressed in our screen (Fig. 1), yet they
have been reported to regulate beta cell mass during
pregnancy [16–21]. The cut-off levels used to screen for
differentially expressed genes may be partly responsible.
Indeed, Foxm1 was significantly upregulated (fold change
1.6) on P9.5 (ESM Fig. 8a), but had only a p value of p=
0.03, while we used p=0.001 as cut-off. On the other hand,
we were not able to detect any decrease in Men1 expression
during pregnancy, neither by microarray (ESM Fig. 8b) nor
by quantitative RT-PCR (results not shown). Therefore the
use of more relaxed criteria could well have retained more
new putative cell cycle genes. In spite of these limitations,
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Fig. 6 Effect of G7e and Fignl1 silencing on proliferation and cell
death of MIN6 cells. MIN6 cells that were transfected (grey in
histograms) with (a) a non-target siRNA (negative control), or siRNA
directed against (b) Fignl1,( c) Kif11 (positive control) or (d) G7e
were loaded with the fluorescent dye CFSE and cultured for 6 days.
The fluorescence intensity was measured by flow cytometry to
evaluate the cell division history via dye dilution. Profiles obtained
were compared with non-transfected control MIN6 cells (control,
white in histograms). Data are representatives of at least three
independent experiments. e MIN6 cells silenced for Kif11, G7e and
Fignl1 were stained with propidium iodide (PI) 48 h after transfection.
The proportion of propidium iodide-positive cells was measured by
flow cytometry and normalised to the non-target (NT) control. Values
in arbitrary units (AU). Data are mean±SEM, n=3,*p<0.05 and **p<
0.01 for difference by Z test from value 1 (non-target control)
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cultured MIN6 cells. a mRNA expression levels after silencing (black
bars) of Dlk1 (negative control), Kif11 (positive control), G7e and
Fignl1 or using a non-target siRNA (white bars); expression was
determined by quantitative RT-PCR. Data are mean±SEM, n≥3, *p<
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for the Z test
2586 Diabetologia (2010) 53:2579–2588genes found to be differentially expressed on P15.5 are
consistent with the recent report by Rieck et al. (ESM
Table 7)[ 22]. In addition, tryptophan hydroxylase-1 (a key
enzyme of serotonin biosynthesis) peaks at that time period.
The companion paper to this manuscript, where we
investigated pregnancy-induced serotonin production in
islets, features data that do not support a role for islet
Tph1 expression in beta cell proliferation during pregnancy
[48].
The last issue to be discussed is whether or not the
orchestrated peak in cell cycle gene mRNA expression at
mid-pregnancy in mouse islets is relevant for changes in
beta cell mass in human pregnancies. Pioneering studies
conducted three decades ago by Van Assche and colleagues
indicated that beta cells of pregnant women can proliferate
so that pancreatic beta cell mass increases >twofold during
pregnancy [49]. Conversely, Butler and colleagues recently
reported [50] a more modest 1.4-fold increase in pancreatic
beta cell area, attributing this to the appearance of single or
small beta cell clusters, rather than to beta cell proliferation
or islet hypertrophy. The differences between these two
studies may be due to sampling errors, or age and cause of
death of the patient. With regard to age, it was recently
reported that beta cells in old mice proliferate to a lesser
degree than in young mice [9]. Indeed, when we repeated
some of our measurements on 6- to 9-month-old mice, we
found less beta cell proliferation than in mice aged 10 to
13 weeks (data not shown), supporting the above point.
In summary, we are the first to report on a coordinated
peak of mRNA expression related to cell cycle genes in
islets at day 9.5 of pregnancy. This diagnostic time course
contrasted with most other differentially expressed genes
unrelated to the cell cycle and allowed us to screen among
poorly characterised genes for novel players in cell
replication like Fignl1 and G7e.
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